NUVB CIK: 1811063

Nuvation Bio Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.77
FY22:
0.67
FY23:
0.62
FY24:
0.53
FY25:
0.57
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.00
FY23:
0.01
FY24:
0.01
FY25:
0.02
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.78
FY22:
0.67
FY23:
0.62
FY24:
0.54
FY25:
0.59

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.01
FY23:
0.01
FY24:
0.06
FY25:
0.08
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.00
FY23:
0.00
FY24:
0.02
FY25:
0.21
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.75
FY22:
0.66
FY23:
0.61
FY24:
0.46
FY25:
0.31
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.78
FY22:
0.67
FY23:
0.62
FY24:
0.54
FY25:
0.59

All amounts in billions USD Data source:SEC EDGAR